Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Claire Mulvey
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Claire Mulvey
Assistant Professor, Medicine, School of Medicine. Authored (or co-authored) 47 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- RayzeBio, Inc.
- ID
- NCT05595460
- Phase
- Phase 1 Lung Cancer Research Study
- Study Type
- Interventional
- Participants
- Expecting 49 study participants
- Last Updated